A leading global pharmaceutical company is looking for manufacturers who can supply or are developing Omalizumab and Dornase alpha formulations for the US market.

Reply

Comments :

bd@qbdbiosciences.com

Hi We have access to Omalizumab entering Phase-1 and Dornase in Phase-3 . Other recombinant and biosimlars are also available for US market for licensing. Please share details of your company on my email id.

14:53,  30 Nov 2018
Reply

hostrinlifesciences@gmail.com

Hii, we do support for the complete formulation development for the same with 3 lab,pilot & commercial batches.

For further requirements please feel free to contact me.

Best Regards,
Andrew P
CEO & MD,
Hostrin Life Sciences,
www.hostringlobal.com
andrew@hostringlobal.com

16:05,  06 Dec 2018
Reply

PharmaCompass – Grow Your Pharma Business Digitally. What is Telmisartan? Telmisartan is an angiotensin II receptor antagonist (ARB) used in the management of hypertension. Generally, angiotensin II receptor blockers (ARBs) such as telmisartan bind to the angiotensin II type 1 (AT1) receptors with high affinity, causing inhibition of the action of angiotensin II on vascular smooth muscle, ultimately leading to a reduction in arterial blood pressure. Recent studies suggest that telmisartan may also have PPAR-gamma agonistic properties that could potentially confer beneficial metabolic effects.

ABOUT
THE PAGE

COLLAPSE